AHS18

In 2015 we were contacted by Dr. Gauree Konijeti, Director of the IBD Program of Gastroenterology at Scripps Clinic in La Jolla, California. Dr. Konijeti told us that a patient had introduced her to the Autoimmune Protocol (AIP), and that she’d like to undertake a medical study of it to evaluate its potential efficacy for patients with Crohn’s and ulcerative colitis. The study was built on the framework of Angie’s diet and lifestyle program, SAD to AIP in SIX, which transitioned participants from a Standard American Diet to AIP over six weeks. Participants then spent five weeks in a maintenance phase. The results of the study were remarkable, with 73% of participants reaching clinical remission by week 6 and maintaining that remission during the maintenance phase. The authors concluded that this result rivals that of most drug therapies for IBD These results help the AIP community put data behind our conviction that this process is benefiting so many of us. More importantly, it opens the door for big conversations with the medical community and massive changes in the standard of care for those with autoimmune diseas. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647120/